These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24819675)

  • 1. Balancing nutrition and serum phosphorus in maintenance dialysis.
    Fouque D; Horne R; Cozzolino M; Kalantar-Zadeh K
    Am J Kidney Dis; 2014 Jul; 64(1):143-50. PubMed ID: 24819675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.
    Gutiérrez OM; Wolf M
    Semin Dial; 2010; 23(4):401-6. PubMed ID: 20557490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action.
    Calvo MS; Sherman RA; Uribarri J
    Am J Kidney Dis; 2019 Apr; 73(4):542-551. PubMed ID: 30686528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most consumed processed foods by patients on hemodialysis: Alert for phosphate-containing additives and the phosphate-to-protein ratio.
    Watanabe MT; Araujo RM; Vogt BP; Barretti P; Caramori JCT
    Clin Nutr ESPEN; 2016 Aug; 14():37-41. PubMed ID: 28531397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Information about phosphorus additives and nutritional counseling].
    Kido S; Nomura K; Sasaki S; Shiozaki Y; Segawa H; Tatsumi S
    Clin Calcium; 2012 Oct; 22(10):1583-91. PubMed ID: 23023640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial Factors That Create Barriers to Managing Serum Phosphorus Levels in Pediatric Dialysis Patients: A Retrospective Analysis.
    Taylor JM; Oladitan L; Degnan A; Henderson S; Dai H; Warady BA
    J Ren Nutr; 2016 Jul; 26(4):270-5. PubMed ID: 26993357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of phosphate binders in chronic kidney disease.
    Ketteler M; Biggar PH
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease.
    Adema AY; de Borst MH; Ter Wee PM; Vervloet MG;
    J Ren Nutr; 2014 May; 24(3):143-50. PubMed ID: 24216259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary trends and management of hyperphosphatemia among patients with chronic kidney disease: an international survey of renal care professionals.
    Fouque D; Cruz Casal M; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB
    J Ren Nutr; 2014 Mar; 24(2):110-5. PubMed ID: 24447438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis.
    Hung KY; Liao SC; Chen TH; Chao MC; Chen JB
    Ther Apher Dial; 2013 Feb; 17(1):72-7. PubMed ID: 23379497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hyperphosphataemia: practices and perspectives amongst the renal care community.
    Nagel CJ; Casal MC; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB; Fouque D
    J Ren Care; 2014 Dec; 40(4):230-8. PubMed ID: 24814866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
    Cupisti A; D'Alessandro C; Baldi R; Barsotti G
    J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate control in chronic uremia: don't forget diet.
    Cupisti A; Morelli E; D'Alessandro C; Lupetti S; Barsotti G
    J Nephrol; 2003; 16(1):29-33. PubMed ID: 12649532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Medical Nutrition Intervention on the Management of Hyperphosphatemia in Hemodialysis Patients with Stage 5 Chronic Kidney Disease: A Case Series.
    Moroșan E; Popovici V; Elian V; Dărăban AM; Rusu AI; Licu M; Mititelu M; Karampelas O
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake.
    Uribarri J
    Semin Dial; 2007; 20(4):295-301. PubMed ID: 17635818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic and inorganic dietary phosphorus and its management in chronic kidney disease.
    Noori N; Sims JJ; Kopple JD; Shah A; Colman S; Shinaberger CS; Bross R; Mehrotra R; Kovesdy CP; Kalantar-Zadeh K
    Iran J Kidney Dis; 2010 Apr; 4(2):89-100. PubMed ID: 20404416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of phosphorus retention in chronic kidney disease: a review.
    Amiri FS
    Clin Exp Nephrol; 2015 Dec; 19(6):985-99. PubMed ID: 26032778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia.
    Guida B; Piccoli A; Trio R; Laccetti R; Nastasi A; Paglione A; Memoli A; Memoli B
    Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):879-84. PubMed ID: 20609572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study.
    Kalantar-Zadeh K; Ficociello LH; Parameswaran V; Athienites NV; Mullon C; Kossmann RJ; Coyne DW
    BMC Nephrol; 2019 Oct; 20(1):396. PubMed ID: 31664928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.